M. Fesneau, E. Champeaux-orange, and C. Hennequin, Anal cancer, Cancer Radiother J Soc Francaise Radiother Oncol, vol.14, issue.1, pp.120-126, 2010.

G. Renehan and A. , Current treatment of anal squamous cell carcinoma, Hematol Oncol Clin North Am. déc, vol.26, issue.6, p.131550, 2012.

G. Nilsson, P. J. Aschele, C. Goh, V. Peiffert, D. Cervantes et al., Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol, vol.40, issue.10, p.116576, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01799935

L. G. Johnson, M. M. Madeleine, L. M. Newcomer, S. M. Schwartz, and J. R. Daling, Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, Cancer. 15 juill, vol.101, issue.2, p.2818, 1973.

A. E. Grulich, I. M. Poynten, D. A. Machalek, J. F. Templeton, D. J. Hillman et al., The epidemiology of anal cancer, Sex Health. déc, vol.9, issue.6, p.5048, 2012.

L. Abramowitz, N. Mathieu, F. Roudot-thoraval, N. Lemarchand, P. Bauer et al., Epidermoid anal cancer prognosis comparison among HIV+ and HIV? patients, Aliment Pharmacol Ther. août, vol.30, issue.4, p.41421, 2009.

N. D. Nigro, V. K. Vaitkevicius, T. Buroker, G. T. Bradley, and B. Considine, Combined therapy for cancer of the anal canal, Dis Colon Rectum. avr, vol.24, issue.2, p.735, 1981.

N. D. Nigro, H. G. Seydel, B. Considine, V. K. Vaitkevicius, L. Leichman et al., Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal, Cancer. 15 mai, vol.51, issue.10, p.18269, 1983.

N. D. Nigro, An evaluation of combined therapy for squamous cell cancer of the anal canal, Dis Colon Rectum. déc, vol.27, issue.12, p.7636, 1984.

N. D. Nigro, V. K. Vaitkevicius, and B. Considine, Dynamic management of squamous cell cancer of the anal canal, Invest New Drugs. avr, vol.7, issue.1, p.839, 1989.

J. A. Ajani, K. A. Winter, L. L. Gunderson, J. Pedersen, A. B. Benson et al., Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial, JAMA. 23 avr, vol.299, issue.16, p.191421, 2008.

V. Vendrely, C. Lemanski, E. François, E. Barbier, B. Hamed et al., OC-0284: First results of the French cohort ANABASE : treatment and outcome in non-metastatic anal cancer, Radiother Oncol. avr, vol.127, p.146, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01962677

S. Everitt, T. Kron, T. Leong, M. Schneider-kolsky, and M. M. Manus, Geographic miss in radiation oncology: Have we missed the boat, J Med Imaging Radiat Oncol, vol.53, issue.5, p.5069, 2009.

J. L. Wright, S. M. Patil, L. Temple, B. D. Minsky, L. B. Saltz et al., Squamous Cell Carcinoma of the Anal Canal: Patterns and Predictors of Failure and Implications for Intensity-Modulated Radiation Treatment Planning, Int J Radiat Oncol, vol.78, issue.4, p.106472, 2010.

P. Das, S. Bhatia, C. Eng, J. A. Ajani, J. M. Skibber et al., Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer, Int J Radiat Oncol. juill, vol.68, issue.3, p.794800, 2007.
DOI : 10.1016/j.ijrobp.2006.12.052

L. A. Dawson, Y. Anzai, L. Marsh, M. K. Martel, A. Paulino et al., Patterns of localregional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer, Int J Radiat Oncol Biol Phys, vol.46, issue.5, pp.1117-1126, 2000.
DOI : 10.1016/s0360-3016(99)00550-7

G. O. Schoenfeld, R. J. Amdur, C. G. Morris, J. G. Li, R. W. Hinerman et al., Patterns of Failure and Toxicity after Intensity-Modulated Radiotherapy for Head and Neck Cancer, Int J Radiat Oncol. juin, vol.71, issue.2, p.37785, 2008.
DOI : 10.1016/j.ijrobp.2007.10.010

A. Mohamed, D. I. Rosenthal, M. J. Awan, A. S. Garden, E. Kocak-uzel et al., Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications, Radiat Oncol. déc, vol.11, issue.1, 2016.

S. Johansen, M. H. Norman, E. Dale, C. D. Amdal, T. Furre et al., Patterns of localregional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer, Radiat Oncol. déc, vol.12, issue.1, 2017.

A. Jemal, E. P. Simard, C. Dorell, A. Noone, L. E. Markowitz et al., Estimation de l'incidence et de la mortalité par cancer en France métropolitaine entre 1980 et 2012-invs.santepubliquefrance.fr 21, JNCI J Natl Cancer Inst. 6 févr, vol.105, issue.3, p.175201, 1975.

S. Grabar, D. Costagliola, and A. Bouvier, Épidémiologie du cancer de l'anus, Cancéro Dig, issue.4, 2011.

C. Hennequin and L. Quero, Radiothérapie du cancer du rectum et du canal anal. 1 janv, 2014.

P. Maingon, . Tg, and J. F. Bosset, Cancer du canal anal

L. Moureau-zabotto, V. Vendrely, L. Abramowitz, C. Borg, E. Francois et al., Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up, vol.49, p.83140, 2017.

J. Fléjou, Anatomie pathologique des cancers du canal anal, Cancéro Dig, issue.4, 2011.

B. G. Czito and C. G. Willett, Current management of anal canal cancer, Curr Oncol Rep. mai, vol.11, issue.3, p.18692, 2009.

P. F. Engstrom, J. P. Arnoletti, A. B. Benson, J. D. Berlin, J. M. Berry et al., NCCN clinical practice guidelines in oncology. Anal carcinoma, J Natl Compr Cancer Netw JNCCN. janv, vol.8, issue.1, p.10620, 2010.

H. E. Uronis and J. C. Bendell, Anal cancer: an overview, The Oncologist. mai, vol.12, issue.5, p.52434, 2007.

J. R. Daling, N. S. Weiss, T. G. Hislop, C. Maden, R. J. Coates et al., Sexual practices, sexually transmitted diseases, and the incidence of anal cancer, N Engl J Med, vol.317, issue.16, p.9737, 1987.

J. R. Daling, M. M. Madeleine, L. G. Johnson, S. M. Schwartz, K. A. Shera et al., Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer, Cancer. 15 juill, vol.101, issue.2, p.27080, 2004.

M. Steinau, E. R. Unger, B. Y. Hernandez, M. T. Goodman, G. Copeland et al., Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction, J Low Genit Tract Dis, vol.17, issue.4, p.397403, 2013.

M. Frisch, B. Glimelius, A. J. Van-den-brule, J. Wohlfahrt, C. J. Meijer et al., Sexually transmitted infection as a cause of anal cancer, N Engl J Med, vol.337, p.13508, 1997.

D. P. Zandberg, R. Bhargava, S. Badin, and K. J. Cullen, The role of human papillomavirus in nongenital cancers, CA Cancer J Clin. janv, vol.63, issue.1, p.5781, 2013.

I. Penn, Cancers of the anogenital region in renal transplant recipients, Cancer. 1 août, vol.58, issue.3, p.6116, 1986.

F. H. Sillman and A. Sedlis, Anogenital papillomavirus infection and neoplasia in immunodeficient women: an update, Dermatol Clin. avr, vol.9, issue.2, p.35369, 1991.

J. M. Palefsky, E. A. Holly, C. J. Hogeboom, M. L. Ralston, M. M. Dacosta et al., Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men, J Acquir Immune Defic Syndr Hum Retrovirology Off Publ Int Retrovirology Assoc. 1 avr, vol.17, issue.4, p.3149, 1998.

J. M. Palefsky, E. A. Holly, M. L. Ralston, S. P. Arthur, N. Jay et al., Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors, J Acquir Immune Defic Syndr Hum Retrovirology Off Publ Int Retrovirology Assoc. 1 avr, vol.17, issue.4, p.3206, 1998.

M. Gr?t, K. Gr?t, W. Ho?ówko, M. Malejczyk, S. Walter-de-walthoffen et al., Initial prevalence of anal human papilloma virus infection in liver transplant recipients, Transpl Int Off J Eur Soc Organ Transplant. août, vol.27, issue.8, p.81623, 2014.

S. Roka, S. Rasoul-rockenschaub, J. Roka, R. Kirnbauer, F. Mühlbacher et al., Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression, Transpl Int Off J Eur Soc Organ Transplant. août, vol.17, issue.7, p.3669, 2004.

D. A. Machalek, M. Poynten, J. F. Fairley, C. K. Farnsworth, A. Garland et al., Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis, Lancet Oncol. mai, vol.13, issue.5, p.487500, 2012.

M. S. Shiels, R. M. Pfeiffer, A. K. Chaturvedi, A. R. Kreimer, and E. A. Engels, Impact of the HIV epidemic on the incidence rates of anal cancer in the United States, J Natl Cancer Inst, vol.104, issue.20, p.15918, 2012.

M. J. Silverberg, B. Lau, A. C. Justice, E. Engels, M. J. Gill et al., Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America, Clin Infect Dis Off Publ Infect Dis Soc Am. avr, vol.54, issue.7, p.102634, 2012.

M. Guiguet, F. Boué, J. Cadranel, J. Lang, E. Rosenthal et al., Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDHANRS CO4): a prospective cohort study, Lancet Oncol. déc, vol.10, issue.12, p.11529, 2009.

C. Piketty, H. Selinger-leneman, A. Bouvier, A. Belot, M. Mary-krause et al., Incidence of HIV-Related Anal Cancer Remains Increased Despite Long-Term Combined Antiretroviral Treatment: Results From the French Hospital Database on HIV, J Clin Oncol. 10 déc, vol.30, issue.35, p.43606, 2012.

E. Y. Chiao, C. M. Hartman, H. B. El-serag, and T. P. Giordano, The impact of HIV viral control on the incidence of HIV-associated anal cancer, J Acquir Immune Defic Syndr, vol.63, issue.5, p.6318, 1999.

M. Bower, T. Powles, T. Newsom-davis, C. Thirlwell, J. Stebbing et al., HIVassociated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?, J Acquir Immune Defic Syndr, vol.37, issue.5, p.15635, 1999.

C. Chao, W. A. Leyden, L. Xu, M. A. Horberg, D. Klein et al., Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons, AIDS Lond Engl, vol.26, issue.17, p.222331, 2012.

J. R. Daling, K. J. Sherman, T. G. Hislop, C. Maden, M. T. Mandelson et al., Cigarette smoking and the risk of anogenital cancer, Am J Epidemiol. 15 janv, vol.135, issue.2, p.1809, 1992.

J. Monsonego, Anal cancer and human papillomaviruses: a perspective based on the cervical cancer model

, Gynecol Obstet Fertil. avr, vol.38, issue.4, p.2504, 2010.

L. Abramowitz, A. Jacquard, F. Jaroud, J. Haesebaert, L. Siproudhis et al., Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study, Int J Cancer. 15 juill, vol.129, issue.2, p.4339, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00563122

V. Vendrely, S. Galland-girodet, M. Orré, and J. Maire, Guidelines for delineation of pelvic lymph nodes in anal cancer treatment, HAS. Haute Autorité de Santé-Évaluation de l'intérêt de la recherche des papillomavirus humains (HPV) dans le dépistage des lésions précancéreuses et cancéreuses du col de l'utérus.HAS.fr 53, vol.17, p.56670, 2013.

T. Boisserie and T. E. Bilan, stadification et indications thérapeutiques des cancers épidermoïdes de l'anus. Résultats de la radiothérapie et de la radiochimiothérapie, Côlon Rectum. 1 mai, vol.5, issue.2, p.5866, 2011.

V. Vendrely, SEER. Anal Cancer-Cancer Stat Facts.-seer.cancer.gov/statfacts/html/anus.html 57. ACIM. Australian Cancer Incidence and Mortality (ACIM) books, ACIM books. Australian Institute of Health and Welfare. 58. Anal Cancer Survival Rates, vol.56, 2017.

J. Lam, M. Rebolj, P. Dugué, J. Bonde, V. Euler-chelpin et al., Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies, J Med Screen. mars, vol.21, issue.1, p.3850, 2014.

A. R. Giuliano, J. M. Palefsky, S. Goldstone, E. D. Moreira, M. E. Penny et al., Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males, N Engl J Med. 3 févr, vol.364, issue.5, p.40111, 2011.

J. M. Palefsky, A. R. Giuliano, S. Goldstone, E. D. Moreira, C. Aranda et al., HPV vaccine against anal HPV infection and anal intraepithelial neoplasia, N Engl J Med, vol.365, issue.17, p.157685, 2011.

N. Jay, J. M. Berry, C. J. Hogeboom, E. A. Holly, T. M. Darragh et al., Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology, Dis Colon Rectum. août, vol.40, issue.8, p.91928, 1997.

B. M. Boman, C. G. Moertel, O. Connell, M. J. Scott, M. Weiland et al., Carcinoma of the anal canal. A clinical and pathologic study of 188 cases, Cancer. 1 juill, vol.54, issue.1, p.128593, 1984.

M. P. Pintor, J. M. Northover, and R. J. Nicholls, Squamous cell carcinoma of the anus at one hospital from 1948 to 1984, Br J Surg. août, vol.76, issue.8, p.80610, 1989.

F. Eschwege, P. Lasser, A. Chavy, P. Wibault, J. Kac et al., Squamous cell carcinoma of the anal canal: treatment by external beam irradiation, Radiother Oncol J Eur Soc Ther Radiol Oncol. févr, vol.3, issue.2, p.14550, 1985.

M. Schlienger, C. Krzisch, F. Pene, J. L. Marin, B. Gindrey-vie et al., Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases, Int J Radiat Oncol Biol Phys. déc, vol.17, issue.6, p.114151, 1989.

R. J. Salmon, B. Zafrani, A. Labib, B. Asselain, J. Girodet et al.,

, Gastroenterol Clin Biol. déc, vol.9, issue.12, p.9117, 1985.

S. Goldman, B. Glimelius, U. Glas, G. Lundell, L. Påhlman et al., Management of anal epidermoid carcinoma-an evaluation of treatment results in two population-based series, Int J Colorectal Dis. déc, vol.4, issue.4, p.23443, 1989.

J. Papillon, M. Mayer, J. F. Montbarbon, J. P. Gerard, J. L. Chassard et al., Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report, Dis Colon Rectum. juin, vol.51, issue.10, p.3546, 1974.

L. Leichman, N. Nigro, V. K. Vaitkevicius, B. Considine, T. Buroker et al., Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy, Am J Med. févr, vol.78, issue.2, p.2115, 1985.

B. Sischy, R. Doggett, J. M. Krall, D. G. Taylor, W. T. Sause et al., Definitive Irradiation and Chemotherapy for Radiosensitization in Management of Anal Carcinoma: Interim Report on Radiation Therapy Oncology Group Study No. 8314, JNCI J Natl Cancer Inst. 7 juin, vol.81, issue.11, p.8507, 1989.

W. R. Meeker, B. J. Sickle-santanello, G. Philpott, D. Kenady, K. I. Bland et al., Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal, Cancer. 1 févr, vol.57, issue.3, p.5259, 1986.

R. A. Michaelson, G. B. Magill, S. H. Quan, R. H. Leaming, M. Nikrui et al., Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma, Cancer. 1 févr, vol.51, issue.3, p.3905, 1983.

B. Cummings, T. Keane, G. Thomas, A. Harwood, and W. Rider, Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy, Cancer, vol.54, issue.10, p.20628, 1984.

G. Tanum, K. Tveit, K. O. Karlsen, and M. Hauer-jensen, Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity, Cancer. 15 mai, vol.67, issue.10, p.24626, 1991.

E. Touboul, M. Schlienger, L. Buffat, D. Lefkopoulos, F. Pène et al., Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients, Cancer. 15 mars, vol.73, issue.6, p.156979, 1994.

J. Martenson, S. Lipsitz, H. Wagner, E. Kaplan, L. Otteman et al., Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An eastern cooperative oncology group study, Int J Radiat Oncol. 1 juill, vol.35, issue.4, p.7459, 1996.

H. Bartelink, F. Roelofsen, F. Eschwege, P. Rougier, J. F. Bosset et al., Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups, J Clin Oncol, vol.15, issue.5, pp.2040-2049, 1997.

A. Allal, J. M. Kurtz, G. Pipard, M. C. Marti, R. Miralbell et al., Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison, Int J Radiat Oncol Biol Phys. 1 sept, vol.27, issue.1, p.5966, 1993.

B. J. Cummings, T. J. Keane, B. O'sullivan, C. S. Wong, and C. N. Catton, Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C, Int J Radiat Oncol Biol Phys, vol.21, issue.5, p.111525, 1991.

, Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research, Lancet Lond Engl, vol.348, issue.9034, p.104954, 1996.

J. Northover, R. Glynne-jones, D. Sebag-montefiore, J. R. Meadows, H. Wan et al.,

, Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I), Br J Cancer. 30 mars, vol.102, issue.7, p.11238, 2010.

M. Flam, M. John, T. F. Pajak, N. Petrelli, R. Myerson et al., Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study, J Clin Oncol, vol.14, issue.9, pp.2527-2539, 1996.

L. L. Gunderson, K. A. Winter, J. A. Ajani, J. E. Pedersen, J. Moughan et al., Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin, J Clin Oncol. 10 déc, vol.30, issue.35, p.434451, 2012.

R. D. James, R. Glynne-jones, H. M. Meadows, D. Cunningham, A. S. Myint et al.,

, Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2$\times$ 2 factorial trial, Lancet Oncol, vol.14, issue.6, pp.516-524, 2013.

D. Peiffert, L. Tournier-rangeard, J. Gérard, C. Lemanski, E. François et al., Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial, J Clin Oncol. juin, vol.30, issue.16, p.19418, 2012.

G. T. Deans, J. J. Mcaleer, and R. A. Spence, Malignant anal tumours, Br J Surg. avr, vol.81, issue.4, p.5008, 1994.

D. P. Ryan, C. C. Compton, and R. J. Mayer, Carcinoma of the anal canal, N Engl J Med. 16 mars, vol.342, issue.11, p.792800, 2000.

H. Sato, P. Koh, and D. Bartolo, Management of anal canal cancer, Dis Colon Rectum. juin, vol.48, issue.6, p.130115, 2005.
DOI : 10.1007/s10350-004-0934-z

J. Y. Bobin, J. P. Gérard, O. Chapet, P. Romestaing, and S. Isaac, Lymphatic mapping and inguinal sentinel lymph node biopsy in anal canal cancers to avoid prophylactic inguinal irradiation, Cancer Radiother J Soc Francaise Radiother Oncol. nov, vol.7, issue.1, pp.85-90, 2003.

D. Koh, C. George, L. Temple, D. J. Collins, P. Toomey et al., Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes, AJR Am J Roentgenol. juin, vol.194, issue.6, pp.505-513, 2010.

Y. X. Wang, S. M. Hussain, G. Krestin, B. T. Nguyen, D. L. Joon et al., Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging, Radiother Oncol J Eur Soc Ther Radiol Oncol. juin, vol.11, issue.11, p.37682, 2001.

. Winton-e-de, A. G. Heriot, M. Ng, R. J. Hicks, A. Hogg et al., The impact of 18fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer, Br J Cancer. 10 mars, vol.100, issue.5, p.693700, 2009.

E. Piperkova, B. Raphael, M. Altinyay, I. Castellon, R. Libes et al., Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review, J BUON Off J Balk Union Oncol. déc, vol.11, issue.4, p.5237, 2006.

S. Tehranian, G. Treglia, D. N. Krag, V. Kakhki, S. R. Zakavi et al., Sentinel Node Mapping in Anal Canal Cancer: Systematic Review and Meta-Analysis, J Gastrointestin Liver Dis, vol.22, issue.3, p.8, 2013.

C. Hirche, S. Dresel, R. Krempien, and M. Hünerbein, Sentinel node biopsy by indocyanine green retention fluorescence detection for inguinal lymph node staging of anal cancer: preliminary experience, Ann Surg Oncol. sept, vol.17, issue.9, p.235762, 2010.

, The role of endosonography in anal cancer, Parades, 1998.

S. Goldman, U. Norming, C. Svensson, and B. Glimelius, Transanorectal ultrasonography in the staging of anal epidermoid carcinoma, Int J Colorectal Dis. août, vol.6, issue.3, p.1527, 1991.

G. Roseau, L. Palazzo, P. Colardelle, S. Chaussade, D. Couturier et al., Endoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal, Gastrointest Endosc. août, vol.40, issue.4, p.44750, 1994.

U. Herzog, M. Boss, and H. P. Spichtin, Endoanal ultrasonography in the follow-up of anal carcinoma, Surg Endosc. oct, vol.8, issue.10, p.11869, 1994.

B. Magdeburg, M. Fried, and C. Meyenberger, Endoscopic ultrasonography in the diagnosis, staging, and follow-up of anal carcinomas, Endoscopy. juin, vol.31, issue.5, p.35964, 1999.

M. Giovannini, V. J. Bardou, R. Barclay, L. Palazzo, G. Roseau et al., Anal carcinoma: prognostic value of endorectal ultrasound (ERUS), Endoscopy, vol.33, issue.03, pp.231-236, 2001.
DOI : 10.1055/s-2001-12860

D. Tarantino and M. A. Bernstein, Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system, Dis Colon Rectum. janv, vol.45, issue.1, p.1622, 2002.

A. F. Christensen, M. B. Nielsen, S. A. Engelholm, H. Roed, L. B. Svendsen et al., Threedimensional anal endosonography may improve staging of anal cancer compared with twodimensional endosonography, Dis Colon Rectum. mars, vol.47, issue.3, p.3415, 2004.

M. Giovannini, J. F. Seitz, G. Houvenaeghel, J. R. Delpero, R. Rosello et al.,

, Presse Medicale Paris Fr 1983. 23 sept, vol.18, p.143940, 1989.

M. W. Stearns, C. Urmacher, S. S. Sternberg, J. Woodruff, and F. Attiyeh, Cancer of the anal canal, Curr Probl Cancer. juin, vol.4, issue.12, p.144, 1980.

S. Goldman, B. Glimelius, U. Norming, L. Påhlman, and U. Seligson, Transanorectal ultrasonography in anal carcinoma. A prospective study of 21 patients, Acta Radiol Stockh Swed, vol.29, issue.3, p.33741, 1987.
DOI : 10.1177/028418518802900315

D. S. Wade, L. Herrera, N. B. Castillo, and N. J. Petrelli, Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique, Surg Gynecol Obstet. sept, vol.169, issue.3, p.23842, 1989.

G. Péley, E. Farkas, I. Sinkovics, T. Kovács, S. Keresztes et al., Inguinal sentinel lymph node biopsy for staging anal cancer, Scand J Surg SJS Off Organ Finn Surg Soc Scand Surg Soc, vol.91, issue.4, p.3368, 2002.

R. H. Cohan, P. M. Silverman, W. M. Thompson, R. A. Halvorsen, and M. E. Baker, Computed tomography of epithelial neoplasms of the anal canal, AJR Am J Roentgenol. sept, vol.145, issue.3, p.56973, 1985.

A. Scherrer, F. Reboul, D. Martin, J. C. Dupuy, and Y. Menu, CT of malignant anal canal tumors, Radiogr Rev Publ Radiol Soc N Am Inc. mai, vol.10, issue.3, p.43353, 1990.
DOI : 10.1148/radiographics.10.3.2188307

D. R. Radin, Squamous cell carcinoma of the anus and rectum in homosexual men: CT findings, J Comput Assist Tomogr. déc, vol.18, issue.6, p.9214, 1994.

C. J. Mcmahon, N. M. Rofsky, and I. Pedrosa, Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging, Radiology. janv, vol.254, issue.1, p.3146, 2010.

D. Prezzi, R. Mandegaran, S. Gourtsoyianni, K. Owczarczyk, A. Gaya et al., The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal, Eur Radiol. avr, vol.28, issue.4, p.15129, 2018.

E. Rusten, B. L. Rekstad, C. Undseth, G. Al-haidari, B. Hanekamp et al., Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography, Radiat Oncol. déc, vol.12, issue.1, 2017.
DOI : 10.1186/s13014-017-0883-z

URL : https://ro-journal.biomedcentral.com/track/pdf/10.1186/s13014-017-0883-z

D. Kulling, D. R. Feldman, C. L. Kay, D. E. Bohning, B. J. Hoffman et al., Local staging of anal and distal colorectal tumors with the magnetic resonance endoscope, Gastrointest Endosc. févr, vol.47, issue.2, p.1728, 1998.

S. C. Roach, P. A. Hulse, F. J. Moulding, R. Wilson, and B. M. Carrington, Magnetic resonance imaging of anal cancer, Clin Radiol, vol.60, issue.10, p.11119, 2005.

C. Anderson, M. Koshy, C. Staley, N. Esiashvili, S. Ghavidel et al., PET-CT fusion in radiation management of patients with anorectal tumors, Int J Radiat Oncol Biol Phys. 1 sept, vol.69, issue.1, p.15562, 2007.

M. Krengli, M. E. Milia, L. Turri, E. Mones, M. C. Bassi et al., FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma, Radiat Oncol Lond Engl. 6 févr, vol.5, p.10, 2010.

J. M. Pepek, C. G. Willett, and B. G. Czito, Radiation therapy advances for treatment of anal cancer, J Natl Compr Cancer Netw JNCCN. janv, vol.8, issue.1, p.1239, 2010.

N. J. Bhuva, R. Glynne-jones, L. Sonoda, W. Wong, and M. K. Harrison, To PET or not to PET? That is the question. Staging in anal cancer, Ann Oncol. 1 août, vol.23, issue.8, p.207882, 2012.

C. Caldarella, S. Annunziata, G. Treglia, R. Sadeghi, N. Ayati et al., Diagnostic Performance of Positron Emission Tomography/Computed Tomography Using Fluorine-18 Fluorodeoxyglucose in Detecting Locoregional Nodal Involvement in Patients with Anal Canal Cancer: A Systematic Review and Meta-Analysis, Sci World J, p.111, 2014.

S. E. Cotter, P. W. Grigsby, B. A. Siegel, F. Dehdashti, R. S. Malyapa et al., FDGPET/CT in the evaluation of anal carcinoma, Int J Radiat Oncol. juill, vol.65, issue.3, p.7205, 2006.

M. Mistrangelo, E. Pelosi, M. Bellò, U. Ricardi, E. Milanesi et al., Role of positron emission tomography-computed tomography in the management of anal cancer, Int J Radiat Oncol Biol Phys. 1 sept, vol.84, issue.1, p.6672, 2012.

T. G. Trautmann and J. H. Zuger, Positron Emission Tomography for Pretreatment Staging and Posttreatment Evaluation in Cancer of the Anal Canal, Mol Imaging Biol. juill, vol.7, issue.4, p.30913, 2005.

A. Mahmud, R. Poon, and D. Jonker, PET imaging in anal canal cancer: a systematic review and meta-analysis, Br J Radiol. déc, vol.90, p.20170370, 1080.
DOI : 10.1259/bjr.20170370

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047643

M. Jones, G. Hruby, M. Solomon, N. Rutherford, and J. Martin, The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis, Ann Surg Oncol, vol.22, issue.11, p.357481, 2015.

H. Sekhar, M. Zwahlen, S. Trelle, L. Malcomson, R. Kochhar et al., Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study, Lancet Oncol, vol.18, issue.10, p.134859, 2017.

R. J. Myerson, M. Garofalo, E. Naqa, I. Abrams, R. A. Das et al., Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas, Int J Radiat Oncol. sept, vol.72, issue.1, p.71, 2008.

F. Denis and Y. Pointreau, Site de radio-anatomie et d'aide à la délinéation (SIRIADE) : présentation et bilan à un an. Cancer/Radiothérapie, vol.14, p.25, 2010.
DOI : 10.1016/s1278-3218(10)70002-0

M. Ng, T. Leong, S. Chander, J. Chu, A. Kneebone et al., Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer, Int J Radiat Oncol. août, vol.83, issue.5, p.145562, 2012.

J. C. Hodges, P. Das, C. Eng, A. G. Reish, A. S. Beddar et al., Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement, Int J Radiat Oncol Biol Phys, vol.75, issue.3, p.7914, 2009.

, A trial looking at higher doses of chemoradiotherapy for people with locally advanced anal cancer (PLATO ACT5). Cancer Research UK, 2017.

J. P. Gerard, O. Chapet, F. Samiei, E. Morignat, S. Isaac et al., Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature, Cancer. 1 juill, vol.92, issue.1, p.7784, 2001.

C. Ortholan, M. Resbeut, J. Hannoun-levi, E. Teissier, J. Gerard et al., Anal Canal Cancer: Management of Inguinal Nodes and Benefit of Prophylactic Inguinal Irradiation (CORS-03 Study), Int J Radiat Oncol. avr, vol.82, issue.5, 2012.

J. Matthews, B. H. Burmeister, M. Borg, A. L. Capp, D. Joseph et al., T1-2 anal carcinoma requires elective inguinal radiation treatment-the results of Trans Tasman Radiation Oncology Group study TROG 99.02, Radiother Oncol J Eur Soc Ther Radiol Oncol. janv, vol.98, issue.1, p.938, 2011.

T. Zilli, U. Schick, M. Ozsahin, P. Gervaz, A. D. Roth et al., Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?, Radiother Oncol J Eur Soc Ther Radiol Oncol. janv, vol.102, issue.1, p.627, 2012.
DOI : 10.1016/j.radonc.2011.09.015

M. D. Chuong, J. M. Freilich, S. E. Hoffe, W. Fulp, J. M. Weber et al., IntensityModulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal, Gastrointest Cancer Res GCR. mars, vol.6, issue.2, p.3945, 2013.

J. G. Bazan, W. Hara, A. Hsu, P. A. Kunz, J. Ford et al., Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal, Cancer. 1 août, vol.117, issue.15, p.334251, 2011.

J. A. Call, M. G. Haddock, J. F. Quevedo, D. W. Larson, and R. C. Miller, Intensity-modulated radiotherapy for squamous cell carcinoma of the anal canal: efficacy of a low daily dose to clinically negative regions, Radiat Oncol Lond Engl, vol.6, p.134, 2011.

L. A. Kachnic, H. K. Tsai, J. J. Coen, L. S. Blaszkowsky, K. Hartshorn et al., Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy, Int J Radiat Oncol Biol Phys. 1 janv, vol.82, issue.1, p.1538, 2012.

M. D. Chuong, S. E. Hoffe, J. Weber, J. M. Freilich, H. Lomas et al., Outcomes of anal cancer treated with definitive IMRT-based chemoradiation, J Radiat Oncol. juin, vol.1, issue.2, p.16572, 2012.

A. B. Chakravarthy, P. J. Catalano, J. A. Martenson, J. K. Mondschein, H. Wagner et al., Long-Term Follow-Up of a Phase II Trial of High-Dose Radiation With Concurrent 5-Fluorouracil and Cisplatin in Patients With Anal Cancer (ECOG E4292), Int J Radiat Oncol, vol.81, issue.4, p.60713, 2011.

R. Doci, R. Zucali, L. Monica, G. Meroni, E. Kenda et al., Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients, J Clin Oncol. déc, vol.14, issue.12, p.31215, 1996.

. Ajani, M. Fluorouracil, and R. Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal, JAMA, vol.299, issue.16, pp.1914-1921, 2008.

L. Capelli, C. Gardini, A. Scarpi, E. Frassineti, G. L. Saragoni et al., No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Sci Rep, vol.25, p.37621, 2016.

C. Gardini, A. Capelli, L. Ulivi, P. Giannini, M. Freier et al., BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC), PloS One, vol.9, issue.3, p.92071, 2014.

M. G. Zampino, E. Magni, A. Sonzogni, and G. Renne, K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?, Cancer Chemother Pharmacol. déc, vol.65, issue.1, p.1979, 2009.

W. Cacheux, E. Rouleau, A. Briaux, P. Tsantoulis, P. Mariani et al., Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection, Br J Cancer, vol.14, issue.12, p.138794, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01478384

J. Mendelsohn and J. Baselga, The EGF receptor family as targets for cancer therapy, Oncogene. 27 déc, vol.19, issue.56, p.655065, 2000.

L. O. Olivatto, F. M. Vieira, B. V. Pereira, A. P. Victorino, M. Bezerra et al., Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma, Cancer. 15 août, vol.119, issue.16, p.297380, 2013.

E. Deutsch, C. Lemanski, J. P. Pignon, A. Levy, A. Delarochefordiere et al., Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial, Ann Oncol Off J Eur Soc Med Oncol. nov, vol.24, issue.11, p.28348, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01798389

A. Levy, D. Azria, J. Pignon, A. Delarochefordiere, I. Martel-lafay et al., Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial, Radiother Oncol J Eur Soc Ther Radiol Oncol. mars, vol.114, issue.3, p.4156, 2015.

C. M. Jones, R. Adams, A. Downing, R. Glynne-jones, M. Harrison et al., Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort, Int J Radiat Oncol Biol Phys. 1 août, vol.101, issue.5, p.120211, 2018.

O. Matzinger, F. Roelofsen, L. Mineur, S. Koswig, E. M. Van-der-steen-banasik et al., Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014), Eur J Cancer Oxf Engl, vol.45, issue.16, p.278291, 1990.
URL : https://hal.archives-ouvertes.fr/hal-00485139

W. B. Gabriel, Squamous-cell Carcinoma of the Anus and Anal Canal: An Analysis of 55 Cases, Proc R Soc Med. janv, vol.34, issue.3, p.13960, 1941.

J. E. Dalby and R. S. Pointon, The treatment of anal carcinoma by interstitial irradiation, Am J Roentgenol Radium Ther Nucl Med. mars, vol.85, p.51520, 1961.

K. Saarilahti, P. Arponen, L. Vaalavirta, and M. Tenhunen, The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer, Radiother Oncol J Eur Soc Ther Radiol Oncol. juin, vol.87, issue.3, p.38390, 2008.

C. Oehler-jänne, B. Seifert, U. M. Lütolf, G. Studer, C. Glanzmann et al., Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma, Brachytherapy. 1 juill, vol.6, issue.3, p.21826, 2007.

L. Moureau-zabotto, C. Ortholan, J. Hannoun-levi, E. Teissier, D. Cowen et al., Role of Brachytherapy in the Boost Management of Anal Carcinoma With Node Involvement (CORS03 Study), Int J Radiat Oncol. mars, vol.85, issue.3, p.13542, 2013.

A. De-la-rochefordière, A. Labib, C. Dauphinot, C. Chira, M. Campitelli et al., Radiothérapie des cancers du canal anal, Cancéro Dig, issue.4, 2011.

A. B. Benson, A. P. Venook, A. -. Hawary, M. M. Cederquist, L. Chen et al., Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Cancer Netw JNCCN. juill, vol.16, issue.7, p.85271, 2018.

D. Peiffert, G. Créhange, V. Vendrely, A. Baumann, J. Faivre et al., Radiotherapy for anal canal cancers, Cancer Radiother J Soc Francaise Radiother Oncol. sept, vol.20, pp.183-188, 2016.

D. Goéré, S. Bonnet, M. Pocard, E. Deutsch, P. Lasser et al., Oncologic and functional results after abdominoperineal resection plus pseudocontinent perineal colostomy for epidermoid carcinoma of the anus, Dis Colon Rectum. mai, vol.52, issue.5, p.95863, 2009.

D. Meulendijks, L. Dewit, N. B. Tomasoa, H. Van-tinteren, J. H. Beijnen et al., Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option, Br J Cancer, vol.111, issue.9, p.172633, 2014.

G. Meadows, H. Wan, S. Gollins, S. Leslie, M. Levine et al., EXTRA-A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer, Int J Radiat Oncol. sept, vol.72, issue.1, p.11926, 2008.

C. Faivre, P. Rougier, M. Ducreux, E. Mitry, A. Lusinchi et al., 5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer, Bull Cancer, vol.86, issue.10, p.8615, 1999.

S. Kim, M. Jary, T. André, V. Vendrely, B. Buecher et al., Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study), BMC Cancer. 25 août, vol.17, issue.1, p.574, 2017.

S. Kim, M. Jary, L. Mansi, B. Benzidane, A. Cazorla et al., DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma, Ann Oncol Off J Eur Soc Med Oncol. déc, vol.24, issue.12, p.304550, 2013.

, Collège National des Gynécologues et Obstétriciens Français, J Gynécologie Obstétrique Biol Reprod. sept, vol.34, issue.5, p.513, 2005.

A. Mervoyer, A. Lisbonna, E. Rio, and M. Mahé, Évaluation de la dose reçue par les organes à risque, Cancer/Radiothérapie. juill, vol.14, issue.45, p.2325, 2010.

C. Lafond, F. Jouyaux, J. Bellec, O. Henry, M. Perdrieux et al., Quelle RCMI ? Du « step and shoot » au VMAT : point de vue du physicien. Cancer/Radiothérapie, vol.14, p.53949, 2010.

G. Lim and F. , Anal cancer: an examination of radiotherapy strategies, Int J Radiat Oncol Biol Phys. 1 avr, vol.79, issue.5, p.1290301, 2011.

M. John, T. Pajak, M. Flam, J. Hoffman, A. Markoe et al., Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08, Cancer J Sci Am. août, vol.2, issue.4, p.20511, 1996.

B. G. Czito and J. Meyer, Radiation therapy in anal and rectal cancer, Surg Oncol Clin N Am. juill, vol.22, issue.3, p.52543, 2013.

A. G. Bentzen, L. Balteskard, E. H. Wanderås, G. Frykholm, T. Wilsgaard et al., Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors, Acta Oncol Stockh Swed. mai, vol.52, issue.4, p.73644, 2013.

K. Fakhrian, T. Sauer, A. Dinkel, S. Klemm, T. Schuster et al., Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature, Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. juin, vol.189, issue.6, p.48694, 2013.

J. J. Meyer, C. G. Willett, and B. G. Czito, Emerging role of intensity-modulated radiation therapy in anorectal cancer, Expert Rev Anticancer Ther. avr, vol.8, issue.4, p.58593, 2008.

T. M. Zagar, C. G. Willett, and B. G. Czito, Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes, Oncol Williston Park N. août, vol.24, issue.9, p.828, 2010.

M. T. Milano, A. B. Jani, K. J. Farrey, C. Rash, R. Heimann et al., Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome, Int J Radiat Oncol Biol Phys, vol.63, issue.2, p.35461, 2005.

J. K. Salama, L. K. Mell, D. A. Schomas, R. C. Miller, K. Devisetty et al., Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience, J Clin Oncol Off J Am Soc Clin Oncol, vol.25, issue.29, p.45816, 2007.

J. M. Pepek, C. G. Willett, Q. J. Wu, S. Yoo, R. W. Clough et al., Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis, Int J Radiat Oncol Biol Phys. 1 déc, vol.78, issue.5, p.14139, 2010.

S. G. Defoe, S. Beriwal, H. Jones, S. Rakfal, D. E. Heron et al., Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma-clinical outcomes in a large National Cancer Institute-designated integrated cancer centre network, Clin Oncol R Coll Radiol G B. août, vol.24, issue.6, p.42431, 2012.

S. Vieillot, P. Fenoglietto, C. Lemanski, C. L. Moscardo, S. Gourgou et al., IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center, Radiat Oncol Lond Engl. 23 mars, vol.7, p.45, 2012.

M. P. Mitchell, M. Abboud, C. Eng, A. S. Beddar, S. Krishnan et al., Intensitymodulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity, Am J Clin Oncol, vol.37, issue.5, p.4616, 2014.

L. A. Kachnic, K. Winter, R. J. Myerson, M. D. Goodyear, J. Willins et al., RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal, Int J Radiat Oncol. mai, vol.86, issue.1, p.2733, 2013.

J. M. Herman and C. R. Thomas, RTOG 0529: Intensity modulated radiation therapy and anal cancer, a step in the right direction?, Int J Radiat Oncol Biol Phys. 1 mai, vol.86, issue.1, p.810, 2013.

C. V. Dewas, P. Maingon, C. Dalban, A. Petitfils, K. Peignaux et al., Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?, Radiat Oncol Lond Engl, vol.7, p.201, 2012.

T. Dasgupta, D. Rothenstein, J. F. Chou, Z. Zhang, J. L. Wright et al., Intensitymodulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: A propensity score analysis, Radiother Oncol. mai, vol.107, issue.2, p.18994, 2013.

A. Yates, S. Carroll, A. Kneebone, R. Tse, L. Horvath et al., Implementing Intensitymodulated Radiotherapy with Simultaneous Integrated Boost for Anal Cancer: 3 Year Outcomes at Two Sydney Institutions, Clin Oncol R Coll Radiol G B. déc, vol.27, issue.12, p.7007, 2015.

P. Franco, M. Mistrangelo, F. Arcadipane, F. Munoz, P. Sciacero et al., Intensitymodulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series, Cancer Invest. juill, vol.33, issue.6, p.25966, 2015.

M. J. Deenen, L. Dewit, H. Boot, J. H. Beijnen, J. Schellens et al., Simultaneous Integrated Boost?Intensity Modulated Radiation Therapy With Concomitant Capecitabine and Mitomycin C for Locally Advanced Anal Carcinoma: A Phase 1 Study, Int J Radiat Oncol. avr, vol.85, issue.5, p.2017, 2013.

N. B. Tomasoa, D. Meulendijks, J. Nijkamp, A. Cats, and L. Dewit, Clinical outcome in patients treated with simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal, Acta Oncol Stockh Swed. juin, vol.55, issue.6, p.7606, 2016.

P. Franco, F. Arcadipane, R. Ragona, M. Mistrangelo, P. Cassoni et al., Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy, Anticancer Res. avr, vol.36, issue.4, p.19438, 2016.

P. Franco, F. Arcadipane, R. Ragona, M. Mistrangelo, P. Cassoni et al., Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy, Anticancer Res. avr, vol.36, issue.4, p.202732, 2016.

L. Belgioia, S. Vagge, A. D. Garelli, S. Murialdo, R. Fornarini et al., Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity, World J Gastroenterol, vol.21, issue.37, p.1068896, 2015.

K. Sakanaka, S. Itasaka, Y. Ishida, K. Fujii, T. Horimatsu et al., Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma, Radiat Oncol J. déc, vol.35, issue.4, p.36879, 2017.

O. Leon, M. G. Guren, C. Radu, A. Gunnlaugsson, and A. Johnsson, Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer, Eur J Cancer Oxf Engl, vol.51, issue.18, p.27406, 1990.

F. Arcadipane, P. Franco, M. Ceccarelli, G. Furfaro, N. Rondi et al., Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer, Asia Pac J Clin Oncol. juin, vol.14, issue.3, p.21723, 2018.

G. Nilsson, P. J. Aschele, C. Goh, V. Peiffert, D. Cervantes et al., Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol. 1 sept, vol.25, issue.3, p.1020, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01799935

A. B. Benson, R. Comprehensive, H. S. Hochster, and L. Saltz, NCCN Guidelines Index Table of Contents, p.51, 2018.

D. M. Koh, A. Dzik-jurasz, O. 'neill, B. Tait, D. Husband et al., Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation, Br J Radiol. févr, vol.81, issue.962, p.918, 2008.

, Common Terminology Criteria for Adverse Events (CTCAE), p.155, 2017.

P. Robinson, B. M. Carrington, R. Swindell, J. H. Shanks, and O. St, Recurrent or residual pelvic bowel cancer: accuracy of MRI local extent before salvage surgery, Clin Radiol. juin, vol.57, issue.6, p.51422, 2002.

G. Sebag-montefiore, D. Adams, R. Gollins, S. Harrison, M. Meadows et al., Prognostic factors for recurrence and survival in anal cancer: Generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I), Cancer. 15 févr, vol.119, issue.4, p.74855, 2013.

D. Martin, P. Balermpas, E. Fokas, C. Rödel, and M. Yildirim, Are there HIV-specific Differences for Anal Cancer Patients Treated with Standard Chemoradiotherapy in the Era of Combined Antiretroviral Therapy, Clin Oncol R Coll Radiol G B, vol.29, issue.4, p.24855, 2017.

D. Grew, D. Bitterman, C. G. Leichman, L. Leichman, N. Sanfilippo et al., HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era, Dis Colon Rectum. déc, vol.58, issue.12, p.11306, 2015.

J. E. Meyer, V. Panico, H. Marconato, D. L. Sherr, C. P. Pirog et al., HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer, J Gastrointest Cancer. déc, vol.44, issue.4, p.4505, 2013.

L. Cunin, M. Alfa-wali, J. Turner, M. Bower, L. Ion et al., Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIVpositive individuals, Ann Surg Oncol. févr, vol.21, issue.2, p.52732, 2014.

S. Johansen, M. H. Norman, E. Dale, C. D. Amdal, T. Furre et al., Patterns of localregional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer, Radiat Oncol. déc, vol.12, issue.1, 2017.

W. T. Ng, M. Lee, W. M. Hung, C. W. Choi, K. C. Lee et al., Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma, Int J Radiat Oncol Biol Phys. 1 févr, vol.79, issue.2, p.4208, 2011.

N. Hodapp, prescribing, recording and reporting photon-beam intensitymodulated radiation therapy, vol.83

, Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. janv, vol.188, issue.1, p.979, 2012.

R. Ferrigno, A. Santos, L. C. Martins, E. Weltman, M. J. Chen et al., Comparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicity, Radiat Oncol Lond Engl. 14 déc, vol.5, p.117, 2010.

K. Han, B. J. Cummings, P. Lindsay, J. Skliarenko, T. Craig et al., Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer, Int J Radiat Oncol Biol Phys, vol.90, issue.3, p.58794, 2014.

G. Sebag-montefiore, D. Meadows, H. M. Cunningham, D. Begum, R. Adab et al., Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial, Lancet Oncol. mars, vol.18, issue.3, p.34756, 2017.

B. Moughan, J. Ajani, J. A. Flam, M. Gunderson, L. Pollock et al., Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11, J Clin Oncol. déc, vol.28, issue.34, p.50616, 2010.

R. Graf, P. Wust, B. Hildebrandt, H. Gögler, R. Ullrich et al., Impact of Overall Treatment Time on Local Control of Anal Cancer Treated with Radiochemotherapy, Oncology, vol.65, issue.1, p.1422, 2003.

R. Muirhead, M. Partridge, and M. A. Hawkins, A tumor control probability model for anal squamous cell carcinoma, Radiother Oncol. août, vol.116, issue.2, p.1926, 2015.

D. Sebag-montefiore, A. R. Bell, S. Berkman, L. Gilbert, D. C. et al., The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus, Int J Radiat Oncol, vol.96, issue.2, p.1645, 2016.

H. Ortholan, C. Resbeut, M. Teissier, E. Ronchin, P. Cowen et al., HighDose Split-Course Radiation Therapy for Anal Cancer: Outcome Analysis Regarding the Boost Strategy (CORS-03 Study), Int J Radiat Oncol. juill, vol.80, issue.3, p.71220, 2011.

M. Mistrangelo, E. Pelosi, M. Bellò, I. Castellano, P. Cassoni et al., Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Inguinal Node Metastases in Patients With Anal Cancer, Int J Radiat Oncol. mai, vol.77, issue.1, p.738, 2010.

J. Sveistrup, A. Loft, A. K. Berthelsen, B. M. Henriksen, M. B. Nielsen et al., Positron emission tomography/computed tomography in the staging and treatment of anal cancer, Int J Radiat Oncol Biol Phys. 1 mai, vol.83, issue.1, p.13441, 2012.

C. J. Brooks, L. Bernier, V. N. Hansen, and D. M. Tait, Target volume motion during anal cancer image guided radiotherapy using cone-beam computed tomography, Br J Radiol. mai, vol.91, p.20170654, 1085.